In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  acetylsalicylic acid
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 55 and over
Sponsor: Other
Protocol IDs: LAL-07OLD, NCT01366898
2.

Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 40 and over
Sponsor: Other
Protocol IDs: ASAPOL, NCT01549418
3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000577892, SINGAPORE-ICR-02, SINGAPORE-ASCOLT, SINGAPORE-07-32-LGI, ICR-02, NCT00565708
4.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 2010-018360-16, NCT01058902
5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GCO 09-1300-00002, P01CA108671, MPD-RC 112, NCT01259856
6.

Phase: Phase III
Type: Prevention
Status: Approved-not yet active
Age: 40 to 60
Sponsor: Other
Protocol IDs: CREAT, NCT01496521
7.

Phase: Phase III
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: Other
Protocol IDs: TIPS-3, NCT01646437
8.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: HEMMYL0018, AR_MM_PI_007, SU-05062011-7711, 19092, NCT01355705
9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: UCI 07-47, NCT00578721
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 40 to 120
Sponsor: NCI
Protocol IDs: NCI-2009-01192, MC054A, R01CA113681, NCT00983580
11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: VICC BMT 1020, NCT01215344
12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GCO 09-1300 001, P01CA108671, MPD-RC 111, NCT01259817
13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RV-MM-PI-0345, NCT01380106
14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: CH-BC-011, NCT01431053
15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: INHANSE-ASPOD, ASPOD, EU-21083, ASPOD, ISRCTN-31503555, EU-21083, NCT01238185
16.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: V1010, NCT01612247
17.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-10055, NCI-2012-00894, NCT01696760
18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: VICC THN 1227, NCI-2012-01800, P50CA090949, NCT01707823
19.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 12-264, NCT01763606
20.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: GN12SU401, 12736, NCT01786200
New Search